Pontow S, Ratner L
Molecular Oncology Division, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
J Virol. 2001 Dec;75(23):11503-14. doi: 10.1128/JVI.75.23.11503-11514.2001.
Human immunodeficiency virus type 1 (HIV-1) infection in vivo is dependent upon the interaction of the viral envelope glycoprotein gp120 with CC chemokine receptor 5 (CCR5) or CXC chemokine receptor 4 (CXCR4). To study the determinants of the gp120-coreceptor association, we generated a set of chimeric HIV-1 coreceptors which express all possible combinations of the four extracellular domains of CCR5 and CXCR4. Stable U87 astroglioma cell lines expressing CD4 and individual chimeric coreceptor proteins were tested against a variety of R5, X4, and R5X4 envelope glycoproteins and virus strains for their ability to support HIV-1-mediated cell fusion and infection, respectively. Each of the cell lines promoted fusion with cells expressing an HIV envelope glycoprotein, except for U87.CD4.5455, which presents the first extracellular loop (ECL1) and flanking sequences of CXCR4 in the context of CCR5. However, all of the chimeric coreceptors allowed productive infection by one or more of the viral strains tested. Viral phenotype was a predictive factor for the observed activity of the chimeric molecules; X4 and R5X4 HIV strains utilized a majority of the chimeras, while R5 strains were limited in their ability to infect cells expressing these chimeric molecules. The expression of CCR5 ECL2 within the CXCR4 backbone supported infection by an R5 primary isolate, but no chimeras bearing the N terminus of CCR5 exhibited activity with R5 strains. Remarkably, the introduction of any CXCR4 domain into the CCR5 backbone was sufficient to allow utilization by multiple X4 strains. However, critical determinants within ECL2 and/or ECL3 of CXCR4 were apparent for all X4 viruses upon replacement of these domains in CXCR4 with CCR5 sequences. Unexpectedly, chimeric coreceptor-facilitated entry was blocked in all cases by the presence of the CXCR4-specific inhibitor AMD3100. Our data provide proof that CCR5 contains elements that support usage by X4 viral strains and demonstrate that the gp120 interaction sites of CCR5 and CXCR4 are structurally related.
1型人类免疫缺陷病毒(HIV-1)在体内的感染依赖于病毒包膜糖蛋白gp120与CC趋化因子受体5(CCR5)或CXC趋化因子受体4(CXCR4)的相互作用。为了研究gp120与共受体结合的决定因素,我们构建了一组嵌合HIV-1共受体,它们表达CCR5和CXCR4四个细胞外结构域的所有可能组合。分别针对多种R5、X4和R5X4包膜糖蛋白及病毒株,检测稳定表达CD4和单个嵌合共受体蛋白的U87星形胶质瘤细胞系支持HIV-1介导的细胞融合及感染的能力。除了U87.CD4.5455(其在CCR5背景下呈现CXCR4的第一个细胞外环(ECL1)及侧翼序列)外,每个细胞系均促进了与表达HIV包膜糖蛋白的细胞的融合。然而,所有嵌合共受体均允许一种或多种所测试病毒株进行有效感染。病毒表型是观察到的嵌合分子活性的预测因素;X4和R5X4 HIV毒株利用了大多数嵌合体,而R5毒株感染表达这些嵌合分子的细胞的能力有限。CXCR4骨架内CCR5 ECL2的表达支持R5原发性分离株的感染,但没有携带CCR5 N端的嵌合体对R5毒株表现出活性。值得注意的是,将任何CXCR4结构域引入CCR5骨架足以允许多种X4毒株利用。然而,当用CCR5序列替换CXCR4中的这些结构域时,对于所有X4病毒而言,CXCR4的ECL2和/或ECL3内的关键决定因素是明显的。出乎意料的是,在所有情况下,CXCR4特异性抑制剂AMD3100的存在均阻断了嵌合共受体促进的病毒进入。我们的数据证明CCR5含有支持X4病毒株利用的元件,并表明CCR5和CXCR4的gp120相互作用位点在结构上相关。